Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Antihyperalgesic effects of bradykinin B2 antagonist from Fujisawa

March 19, 1997

FDA approves Ohmeda's neuromuscular blocking agent

March 19, 1997

BioChem Pharma synthesizes opioid analgesics/NMDA antagonists

March 19, 1997

Cephalon discloses cysteine/serine protease inhibitors

March 19, 1997

Avonex approved by European Commission

March 18, 1997

Lanepitant not effective in migraine

March 18, 1997

Pharmacodynamics and safety of the dopamine agonist CI-1007

March 18, 1997

Topical anesthesia with liposome-encapsulated tetracaine

March 18, 1997

Neuroprotective, analgesic and antitussive agents from Toray

March 18, 1997

Aricept cleared for marketing in U.K.

March 17, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 16, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...